Pilot injection reverses hypotony vision loss

A Moorfields pilot study reports an intraocular injection that restored useful vision in 7 of 8 patients with hypotony, a condition where dangerously low eye pressure causes the eyeball to cave in. The result is a first‑of‑kind clinical signal that needs larger randomized trials, long‑term safety follow‑up, and planning for regulatory review and treatment access. — If confirmed, the therapy would change standards of care for a disabling eye disease, raise urgent questions about trial replication, approval timelines, equity of access, and how health systems budget for transformative single‑procedure cures.